Prana raises US$3.7 million
Wednesday, 08 December, 2004
A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.
The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.
The exercise of options increases the total issued shares in Prana to 126,890,821.
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
